Adi Mor
Fortune : 1 M $ au 31/05/2026
Fortune : 1 M $ au 31/05/2026
Adi Mor is the founder of Chemomab Therapeutics Ltd. since 2011, holding the title of CEO, Director & Chief Scientific Officer since 2023.
Dr. Mor was the founder of Chemomab Ltd. since 2011, holding the title of Director, Chief Executive & Scientific Officer from 2011 to 2021.
Dr. Mor holds a doctorate from Tel-Aviv University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2026 | 10 346 160 ( 2,5 % ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Directeur Général | 01/06/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
Chemomab Ltd.
Chemomab Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops therapeutics for fibro-inflammatory diseases | Directeur Général | 16/03/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chemomab Ltd.
Chemomab Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops therapeutics for fibro-inflammatory diseases | Commercial Services |
Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national